Biotech Exec Nominated to Chevron Board

Kevin W. Sharer has been nominated for election to Chevron's board of directors. Sharer, 59, is currently Chief Executive Officer and President of Amgen Inc., a biotechnology company. Sharer will be part of the slate of board nominees to be considered for election to Chevron's board at the company's 2007 annual meeting of stockholders. If he is elected, the board will expand from 13 to 14 members.

Sharer has been Amgen's CEO and president since May 2000, and has also been chairman of the company's board of directors since January 2001. From October 1992 to May 2000, Sharer was Amgen's president and chief operating officer. He has been a director of Amgen since November 1992.

Before joining Amgen, Sharer was president of the Business Markets Division of MCI Communications. Prior to MCI, Sharer served in a variety of executive capacities at General Electric and was a consultant for McKinsey and Co.

Sharer also serves on the board of directors of Northrop Grumman Corporation, the U.S. Naval Academy Foundation and, until his term expires on May 8, 2007, 3M. He is chairman of the board of trustees of the Los Angeles County Museum of Natural History and a member of the Business Council.

Sharer earned a bachelor's degree in aeronautical engineering from the U.S. Naval Academy and a master's degree in aeronautical engineering from the U.S. Naval Postgraduate School. He also earned a master's degree in business administration from the University of Pittsburgh.